Pancreatic cancer: The clinical trial landscape and progress for 2024

Pancreatic cancer is resistant to conventional therapies, but cutting-edge research may improve survival rates and patient quality of life.

Sep 24, 2024 - 04:00

Pancreatic cancer: The clinical trial landscape and progress for 2024

Pancreatic cancer is resistant to conventional therapies, but cutting-edge research may improve survival rates and patient quality of life.

Read the original article

Tags:

Previous Article

Sanofi gains exclusivity rights to Ventyx’s CNS-penetrant drug in $27m deal

Pharmaceutical Compliance Management Software for the Pharmaceutical Industry

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Simtra BioPharma to invest more than $250m in US facility

Simtra BioPharma to invest more than $250m in US facility

Mar 1, 2024

Takeda, Janssen join wearable maker to measure scratching, and other health tech news

Takeda, Janssen join wearable maker to measure scratchi...

Dec 1, 2023

Access to new tools to combat RSV in babies likely to prove challenging

Access to new tools to combat RSV in babies likely to p...

Oct 6, 2023